Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.

R. Melo (Uberlândia, Brazil), M. Gomes (Uberlândia, Brazil), V. Oliveira (Uberlândia, Brazil), D. Scheucher (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), L. Goulart Filho (Uberlândia, Brazil), D. Brito (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil)

Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Session: Epidemiology and prognostication of critically-ill patients
Session type: Poster Discussion
Number: 318
Disease area: Respiratory critical care

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Melo (Uberlândia, Brazil), M. Gomes (Uberlândia, Brazil), V. Oliveira (Uberlândia, Brazil), D. Scheucher (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), L. Goulart Filho (Uberlândia, Brazil), D. Brito (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil). Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.. 318

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative study of clinical diagnostic criteria for ventilator-associated pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Community-acquired pneumonia. Prospective inpatient study
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006

Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study
Source: Eur Respir J 2005; 26: Suppl. 49, 255s
Year: 2005

Community-acquired pneumonia in the elderly: Spanish multicentre study
Source: Eur Respir J 2003; 21: 294-302
Year: 2003



Management of community-acquired pneumonia in primary care: an observational study
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019


The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


New evidence of risk factors for community-acquired pneumonia: a population-based study
Source: Eur Respir J 2008; 31: 1274-1284
Year: 2008



The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Etiology of community-acquired pneumonia: an autopsy study
Source: Annual Congress 2006 - Miscellaneous respiratory infections I
Year: 2006

Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Clinical stability predictors and length of stay in adults with community-acquired pneumonia. Prospective cohort
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005

Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006

Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
Source: Eur Respir J 2009; 34: 1364-1375
Year: 2009



New approaches to the aetiological diagnosis of VAP
Source: Eur Respir Mon 2011; 53: 11-23
Year: 2011


Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study.
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017